Diagnostic and Statistical Manual of Mental Disorders

Author(s):  
Janet B. W. Williams ◽  
Michael First

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association is referred to as DSM-5™. DSM-5’s early predecessor, DSM-III, differed considerably from the first two editions. Its innovative incorporation of specified diagnostic criteria had a major impact on the field of mental health. In DSM-5, these criteria have been further updated to reflect the important gains in our understanding of mental disorders.

2018 ◽  
Author(s):  
Lancer Naghdechi ◽  
Atef Bakhoum ◽  
Waguih William IsHak

In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), gender dysphoria (GD), previously known as gender identity disorder, is defined as distress or impairment in psychosocial, occupational, educational, or other areas of life due to a perceived disagreement between a person’s assigned gender, natal gender, and the gender currently experienced or expressed for at least 6 months. The DSM-5 mentions that one’s experienced gender may be outside of binary gender stereotypes. Diagnostic criteria are different for GD in children and in adolescents/adults. This review covers the definition, epidemiology, etiology/genetics, clinical manifestations, and studies/tests/treatments related to GD. Tables list the diagnostic criteria for GD and definitions of common terms. This review contains 2 tables and 30 references Key words: DSM-5, gender dysphoria, sexual reassignment surgery


2019 ◽  
Vol 28 (8) ◽  
pp. 932-948 ◽  
Author(s):  
Melissa Roy ◽  
Marie-Pier Rivest ◽  
Dahlia Namian ◽  
Nicolas Moreau

Since its initial publication, the Diagnostic and Statistical Manual of Mental Disorders has been the object of criticism which has led to regular revisions by the American Psychiatric Association. This article analyses the debates that surrounded the publication of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Building on the concepts of public arenas and reception theory, it explores the meaning encoded in the manual by audiences. Our results, which draw from a thematic analysis of traditional and digital media sources, identify eight audiences that react to the American Psychiatric Association’s narrative of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.): conformist, reformist, humanist, culturalist, naturalist, conflictual, constructivist and utilitarian. While some of their claims present argumentative polarities, others overlap, thus challenging the idea, often presented in academic publications, of a fixed debate. In order to further discuss on the Diagnostic and Statistical Manual of Mental Disorders, we draw attention to claims that ‘travel’ across different communities of audiences.


2015 ◽  
Vol 17 (2) ◽  
pp. 109-124 ◽  
Author(s):  
Ester Holte Kofod

Grief is sometimes poetically described as the price of love: An inescapable existential condition of human life. However, throughout the 20th century, grief has increasingly come to be understood as a pathological condition that requires psychological and/or medical intervention. With the release ofDiagnostic and Statistical Manual of Mental Disorders(5th ed.,DSM-5; American Psychiatric Association, 2013), grief came close to being included as a separate mental disorder. However, the diagnostic revisions concerning bereavement have been met with criticism of medicalizing grief and of exceeding the territory of psychiatry beyond its legitimate borders. On this basis, I argue that grief is currently a border diagnosis, that is, a condition whose meanings are informed in heterogeneous ways by medical, psychiatric, and psychological understandings yet constantly challenged by alternative, nonmedicalizing discourses. Drawing on empirical findings from an ongoing interview study with bereaved parents after infant loss, I analyze and discuss 4 different accounts concerning the question of diagnosing grief: (a) diagnosis as a legitimating and normalizing practice, (b) diagnosis as a demarcation practice, (c) diagnosis as pathologization, and (d) diagnosis as a normative ideal. Through the examples, I attempt to demonstrate how bereaved individuals do not merely passively adopt but reflectively use these kinds of understandings to deal with their grief.


Psychology ◽  
2011 ◽  
Author(s):  
Thomas Widiger

Mental health professionals and scientists must have a common language to communicate with their colleagues, with professional agencies, and with patients and the general public. The primary purpose of an official, authoritative diagnostic nomenclature is to provide this common language that minimizes the use of idiosyncratic and invalid concepts. The American Psychiatric Association’s (APA’s) Diagnostic and Statistical Manual of Mental Disorders (DSM-5) provides this common language for the description of psychopathology. DSM-5 is the current edition of the APA’s diagnostic manual.


Diagnosis ◽  
2016 ◽  
Vol 3 (1) ◽  
pp. 9-12
Author(s):  
Kerry G. Baker

AbstractDespite differing target audiences and scope it is possible to compare the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington: American Psychiatric Association, 2013] and the Second International Working Group for New Research Criteria for the Diagnosis of Alzheimer’s Disease (IWG-2) [Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29] diagnostic criteria for both Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). With regard to the diagnosis of AD the principal difference is the inclusion of biomarkers in the IWG-2 diagnostic criteria for this condition. This creates a number of difficulties including a lack of regulatory approval, cultural and other objections to the collection of cerebrospinal fluid (CSF), and a lack of facilities for collection and analysis restricting analysis of CSF proteins to larger tertiary centres [Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29]. With regard to diagnostic criteria for DLB, IWG-2 research criteria designate the co-occurrence of AD and DLB as ‘mixed AD’. However, Alzheimer’s type pathology (ADTP) and Lewy body pathology frequently occur together rendering a separate ‘mixed AD’ category superfluous. The reality is that routine clinical diagnosis of AD and DLB will continue to be based on a thorough general and neurological examination indicating a preponderance of signs and symptoms for one or other of these conditions [Seeley WW, Miller BL. Alzheimer’s disease and other dementias. In: Hauser SL, Josephson SA, editors. Harrison’s neurology in clinical medicine, 3rd ed. New York: McGraw Hill, 2013]. Similarly, AD and DLB research will continue to primarily depend on clinically focussed DSM-5 criteria, making DSM-5 superior to IWG-2 in both clinical and research settings.


Author(s):  
Ειρήνη Μούτσου ◽  
Ευγενία Γεωργάκα

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM- 5) was released by the American Psychiatric Association in May 2013 and has provoked a broad scientific discussion, since it entails significant changes in relation to its previous editions. The current paper offers a review of this discussion, with emphasis on the main changes that are under dispute. Initially, we discuss the developmental course of the various editions of the DSM, the main principles and practices of the current edition as well as the main points of critique against it. We then examine in more detail some significant changes in particular diagnostic categories and their expected implications for the diagnosis and treatment of these mental disorders. In conclusion, the main critique against DSM-5 is that it seems to intensify the medicalisation of mental disorders, which characterises its latest editions, to pathologise a range of everyday experiences and behaviours, and to broaden the diagnosed population, especially to children and the elderly, expanding possibly the use of medication to new age groups.


Author(s):  
Amy Krain Roy ◽  
Melissa A. Brotman ◽  
Ellen Leibenluft

Pediatric irritability is one of the most common reasons for mental health evaluation and treatment. Irritability is transdiagnostic; while it is the hallmark symptom of disruptive mood dysregulation disorder, a new diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), it also appears in the diagnostic criteria for several mood, anxiety, and behavioral disorders and is a common correlate in others. The past 15 years have witnessed a rise in clinical neuroscience studies of pediatric irritability, resulting in significant advances in our understanding of its neural, genetic, psychophysiological, and behavioral correlates. These advances are detailed in the chapters in this volume. There is a particular focus on the implications of these findings for assessment and treatment of irritable youth, along with suggestions for further research.


Sign in / Sign up

Export Citation Format

Share Document